Wegovy pill
Daily oral semaglutide. Morning fasting and water rules apply.
Compare details →Medication-by-medication review · updated October 26, 2026
Evidence brief: Compounded oral GLP-1s: what is and is not approved
Evidence, regulatory labeling and study-context review. Independent review of compounded oral semaglutide, drops, dissolving tablets and oral tirzepatide marketing. Compare evidence, approvals and safety red flags.
Current status
Not an FDA-approved oral weight-management product. Avoid advertisements claiming the FDA has approved this formulation. See FDA guidance.
Regulatory evidence and interpretation
FDA-approved oral GLP-1 pills and compounded drops, oral-dissolving tablets, capsules or other formulations are not interchangeable categories. Compounded medications are not FDA-approved and FDA does not evaluate each finished formulation for safety, efficacy or quality before sale. Generic pharmacy claims of “same ingredient” do not establish the bioavailability of an unusual oral formulation.
- There is no FDA-approved oral tirzepatide product. Foundayo is orforglipron, a different medicine.
- Claims that a compounded sublingual or dissolving semaglutide format works like an approved swallowed tablet need product-specific clinical evidence; do not assume equivalence.
- FDA flags problems with unapproved GLP-1 products, including fraudulent labeling, inaccurate dosing, and some semaglutide salt forms.
- A legitimate pharmacy requires a valid prescription and should identify its licensing, dispenser and preparation. Compounding is subject to legal restrictions.
Why there is no “buy this drop” link
We have not independently verified an FDA-approved oral tirzepatide, a medication-specific affiliate program with adequate evidence for compounded oral formulations, or a safe basis for promoting one as interchangeable with an approved brand pill. For a branded pill, use the direct, untracked options below.
Useful next steps
Cross-check current labeling and dispensing details before following promotional claims. These primary sources are more reliable than uncited provider-ranking or affiliate claims.
Official FDA-linked drug label or safety guidance →Related medication guides
Foundayo
Daily orforglipron. May be taken with or without food.
Compare details →Rybelsus
Daily oral semaglutide. Not approved specifically for weight loss.
Compare details →Compounded oral GLP-1s
Compounded drops, dissolving tablets and other forms have not been FDA-reviewed.
Compare details →Editorial and commercial disclosure
This site provides independently written comparison information, not medical care. Some older articles contain historical prices and provider references. Medication-specific Sesame, manufacturer, and FDA links on this page are untracked editorial links; a commission relationship for those precise landing pages has not been established. Any separately marked sponsored program is not guaranteed to prescribe this medication.
Sources are linked on the page; verify latest labeling, current price, availability, insurance conditions and eligibility with the manufacturer, licensed clinician and dispensing pharmacy. Do not start, switch or combine prescription GLP-1 medications without medical advice. This page does not provide individualized prescribing instructions.